Neutrophil-to-Lymphocyte Ratio and Early Tumor Shrinkage as Predictive Biomarkers in Unresectable Hepatocellular Carcinoma Patients Treated With Lenvatinib, PD-1 Inhibitors, in Combination With TACE

Purpose: The purpose of this prospective observational study was to investigate the relationship between pretreatment neutrophil-to-lymphocyte ratio (NLR) and posttreatment early tumor shrinkage (ETS), and clinical outcomes in patients with unresectable hepatocellular carcinoma (uHCC) who received l...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Shuping, Wu, Dong, Hu, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Advances in the Diagnosis and Treatment of Gastrointestinal Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585992/
https://www.ncbi.nlm.nih.gov/pubmed/37849287
http://dx.doi.org/10.1177/15330338231206704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585992/
https://www.ncbi.nlm.nih.gov/pubmed/37849287
http://dx.doi.org/10.1177/15330338231206704

Ejemplares similares